{"schema_version":"1","generated_at":"2026-11-03T16:59:14.087Z","data_as_of":null,"url":"https://www.findmykol.com/kol/emmanuel-besa","json_url":"https://www.findmykol.com/kol/emmanuel-besa/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"emmanuel-besa","name":"Emmanuel Besa","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Thomas Jefferson University","institution_url":"https://www.findmykol.com/institution/thomas-jefferson-university","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1114947967","openalex":"A5046388594"},"summary":"Emmanuel Besa is an Oncology physician affiliated with Thomas Jefferson University. OpenAlex indexes 96 publications with 2,200 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":96,"cited_by_count":2200,"h_index":26,"latest_activity_year":2023,"source":"works"},"trials":{"count":1,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00699842","title":"A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","source_url":"https://clinicaltrials.gov/study/NCT00699842","trial_url":"https://www.findmykol.com/trial/NCT00699842"},{"nct":"NCT00003619","title":"Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia","phase":"PHASE1/PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Drexel University College of Medicine","source_url":"https://clinicaltrials.gov/study/NCT00003619","trial_url":"https://www.findmykol.com/trial/NCT00003619"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Collegium Pharmaceutical, Inc.","program_year":2023,"amount_usd":63.77,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114947967"},{"payer":"Averitas Pharma Inc.","program_year":2023,"amount_usd":46,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114947967"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1114947967","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide","year":2020,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-020-0979-6","status":"verified"},{"title":"Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide","year":2014,"journal":"Annals of Hematology","source_url":"https://doi.org/10.1007/s00277-014-2022-3","status":"verified"},{"title":"Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome","year":2012,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2010.34.1222","status":"verified"},{"title":"HHV-8–Associated Multicentric Castleman's Disease in HIV-Negative Patient: A Novel Therapy for an Orphan Disease","year":2011,"journal":"The Oncologist","source_url":"https://doi.org/10.1634/theoncologist.2011-0226","status":"verified"},{"title":"Two-Year Analysis of Efficacy and Safety of Deferasirox (Exjade®) Treatment in Myelodysplastic Syndrome Patients Enrolled in the US03 Study.","year":2009,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.v114.22.3829.3829","status":"verified"}],"source":"works"},"contact":{"address_1":"111 S 11TH ST","address_2":"SUITE 4240","city":"Philadelphia","state":"PA","zip":"191074824","phone":"215-955-8874","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1114947967","source":"identity"},"similar":[{"name":"David Whellan","slug":"david-whellan","institution":"Thomas Jefferson University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/david-whellan","json_url":"https://www.findmykol.com/kol/david-whellan/profile.json"},{"name":"Howard Eisen","slug":"howard-eisen","institution":"Thomas Jefferson University","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/howard-eisen","json_url":"https://www.findmykol.com/kol/howard-eisen/profile.json"},{"name":"Jesse Roman","slug":"jesse-roman","institution":"Thomas Jefferson University","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/jesse-roman","json_url":"https://www.findmykol.com/kol/jesse-roman/profile.json"},{"name":"Russell Schilder","slug":"russell-schilder","institution":"Thomas Jefferson University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/russell-schilder","json_url":"https://www.findmykol.com/kol/russell-schilder/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-05-26","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}